Supplemental material
Epigenetics
Volume 14, 2019 - Issue 11
Open access
2,853
Views
22
CrossRef citations to date
0
Altmetric
Research Paper
EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia
Subazini Thankaswamy KosalaiDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenView further author information
, Mohammad Hamdy Abdelrazak MorsyDepartment of Clinical chemistry and Transfusion medicine, Sahlgrenska University Hospital, Gothenburg, SwedenView further author information
, Nikos PapakonstantinouInstitute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, GreeceView further author information
, Larry MansouriDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, SwedenView further author information
, Niki StavroyianniHematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, GreeceView further author information
, Chandrasekhar KanduriDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenView further author information
, Kostas StamatopoulosInstitute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, GreeceView further author information
, Richard RosenquistDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, SwedenView further author information
& Meena KanduriDepartment of Clinical chemistry and Transfusion medicine, Sahlgrenska University Hospital, Gothenburg, SwedenCorrespondence[email protected]
View further author information
show allView further author information
Pages 1125-1140
|
Received 06 Apr 2019, Accepted 13 Jun 2019, Published online: 26 Jun 2019
Related Research Data
EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia
Source:
Taylor & Francis
EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukemia
Source:
Taylor & Francis
EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.